Cytochrome P450 2D6 and outcomes of adjuvant tamoxifen therapy: results of a meta-analysis Bostjan SerugaEitan Amir Review 08 May 2010 Pages: 609 - 617
Diagnosis and management of primary breast sarcoma Sammy Al-BennaKerstin PoggemannLars Steinstraesser Review 18 May 2010 Pages: 619 - 626
Should bisphosphonates be utilized in the adjuvant setting for breast cancer? Allan Lipton Review 21 May 2010 Pages: 627 - 636
Papillary carcinoma of the breast: an overview Sumanta Kumar PalSean K. LauGeorge Somlo Review 04 June 2010 Pages: 637 - 645
Evidence for a tumor promoting effect of high-fat diet independent of insulin resistance in HER2/Neu mammary carcinogenesis Sarah KhalidDavid HwangI. George Fantus Preclinical study 23 October 2009 Pages: 647 - 659
High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation Caryl J. AntalisTyler ArnoldRafat A. Siddiqui Preclinical study 23 October 2009 Pages: 661 - 670
High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer Gitana Maria AcetoAngela Rosaria SolanoErnesto Jorge Podestà Preclinical study 23 October 2009 Pages: 671 - 683
EGFR over-expression and activation in high HER2, ER negative breast cancer cell line induces trastuzumab resistance Rajiv DuaJianhuan ZhangGordon Parry Preclinical study 27 October 2009 Pages: 685 - 697
Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer Tomoko FujikaneNoriko NishikawaTakashi Tokino Preclinical study 27 October 2009 Pages: 699 - 710
Analysis of breast cancer related gene expression using natural splines and the Cox proportional hazard model to identify prognostic associations Bas KreikeGuus HartMarc J. van de Vijver Preclinical study 27 October 2009 Pages: 711 - 720
BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer Julia J. GorskiColin R. JamesD. Paul Harkin Preclinical study 31 October 2009 Pages: 721 - 731
Identification and comprehensive characterization of large genomic rearrangements in the BRCA1 and BRCA2 genes Jesús del ValleLídia FeliubadalóConxi Lázaro Preclinical study 06 November 2009 Pages: 733 - 743
Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model Ianko D. IankovPavlos MsaouelEvanthia Galanis Preclinical study 06 November 2009 Pages: 745 - 754
SLC37A1 Gene expression is up-regulated by epidermal growth factor in breast cancer cells Domenico IacopettaRosamaria LappanoVincenza Dolce Preclinical study 06 November 2009 Pages: 755 - 764
Clinical relevance of the putative stem cell marker p63 in breast cancer L. HankerT. KarnA. Rody Preclinical study 07 November 2009 Pages: 765 - 775
Targeting breast stem cells with the cancer preventive compounds curcumin and piperine Madhuri KakaralaDean E. BrennerMax S. Wicha Preclinical Study 07 November 2009 Pages: 777 - 785
Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group Study Janine L. MansiAnn YellowleesT. R. Jeffry Evans Clinical trial 18 June 2010 Pages: 787 - 794
The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures Liheng ZhouYiwei JiangJinsong Lu Clinical trial 23 June 2010 Pages: 795 - 801
Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis Irit Ben-AharonAnat Gafter-GviliSalomon M. Stemmer Clinical trial 23 June 2010 Pages: 803 - 811
Variants in DNA double-strand break repair genes and risk of familial breast cancer in a South American population Lilian JaraKaren DuboisPatricio González-Hormazábal Epidemiology 07 January 2010 Pages: 813 - 822
Obesity and weight change in relation to breast cancer survival Xiaoli ChenWei LuXiao Ou Shu Epidemiology 08 January 2010 Pages: 823 - 833
The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis Weiguang YuanLidan XuDianjun Li Epidemiology 08 January 2010 Pages: 835 - 842
Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis Myrthe P. P. van Herk-SukelLonneke V. van de Poll-FranseRon M. C. Herings Epidemiology 08 January 2010 Pages: 843 - 851
No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis Ke-Da YuAo-Xiang ChenZhi-Ming Shao Epidemiology 14 January 2010 Pages: 853 - 858
Medical comorbidities predict mortality in women with a history of early stage breast cancer Ruth E. PattersonShirley W. FlattJohn P. Pierce Epidemiology 14 January 2010 Pages: 859 - 865
IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls Li-Xin QiuLei YaoXi-Chun Hu Epidemiology 19 January 2010 Pages: 867 - 871
Socioeconomic disparities in the decline in invasive breast cancer incidence Brian L. SpragueAmy Trentham-DietzElizabeth S. Burnside Epidemiology 20 January 2010 Pages: 873 - 878
The association between TA-repeat polymorphism in the promoter region of UGT1A1 and breast cancer risk: a meta-analysis Lei YaoLi-Xin QiuLong Yu Epidemiology 20 January 2010 Pages: 879 - 882
Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall Emelie StyringJosefin FernebroFredrik Vult von Steyern Epidemiology 20 January 2010 Pages: 883 - 887
Diagnostic work-up of contralateral breast cancers has not improved over calendar period Maria E. C. SandbergMikael HartmanKamila Czene Epidemiology 28 January 2010 Pages: 889 - 895
Methylenetetrahydrofolate reductase C677T polymorphism in breast cancer risk Aydan EroğluNejat Akar Letter to the Editor 14 May 2010 Pages: 897 - 898
Human papillomavirus is not associated with breast carcinoma Dilek YavuzerTaflan SalepciZafer Kucukodaci Letter to the Editor 03 June 2010 Pages: 899 - 900
